References Blundell, J., Finlayson, G., Axelsen, M., et al
Insulin resistance and PCOS: Patients with severe insulin resistance or polycystic ovary syndrome (PCOS) may have a more complex metabolic profile that requires additional intervention beyond GLP-1 therapy alone
Aim for 80-100g protein daily minimum
Semaglutide may be considered for individuals who: Have a body mass index (BMI) of 30 or higher Have a BMI of 27 or higher with at least one weight-related condition, such as hypertension or type 2 diabetes Have struggled to achieve weight loss through diet and exercise alone Its important to note that semaglutide is not suitable for everyone
93% of type 2 diabetes mellitus patients were treated with ACEi, ARB, or ARNI (11%), 97% with beta-blocker, 71% with MRA, 95% with diuretic and 27% had an implantable device (with defibrillator function)
Research on weight loss generally reports that higher protein intake and resistance training are associated with better preservation of lean mass during a calorie deficit